A three-week schedule of gemcitabine plus cisplatin as induction chemotherapy for stage III non-small cell lung cancer (NSCLC): final results of a monoinstitutional phase II study
European Journal of Cancer（2001）
Key words
phase ii study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined